Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.72 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.72 |
| ▸ | LMNA | P02545 | 2/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.72 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.70 |
| ▸ | PDK1 | Q15118 | 2/20 | 0.70 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.70 |
| ▸ | PDK3 | Q15120 | 2/20 | 0.70 |
| ▸ | PDK4 | Q16654 | 2/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.70 |
| ▸ | MAPT | P10636 | 2/20 | 0.70 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.70 |
| ▸ | SLCO1B3 | Q9NPD5 | 1/20 | 0.70 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.70 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.70 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.70 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.70 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.70 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11065471 | 1.00 | ALOX15 (0.72) | ALOX15ALDH1A1LMNAMAPK1HSD17B10 | |
| SCHEMBL18431213 | 1.00 | ALOX15 (0.72) | ALOX15ALDH1A1LMNAMAPK1HSD17B10 | |
| SCHEMBL131104 | 0.87 | ALOX15 (0.69) | ALOX15ALDH1A1LMNAMAPK1HSD17B10 | |
| SCHEMBL131103 | 0.87 | ALOX15 (0.69) | ALOX15ALDH1A1LMNAMAPK1HSD17B10 | |
| SCHEMBL19696487 | 0.85 | ALOX15 (0.69) | ALOX15ALDH1A1LMNAMAPK1HSD17B10 | |
| SCHEMBL18663761 | 0.85 | ALOX15 (0.69) | ALOX15ALDH1A1LMNAMAPK1HSD17B10 | |
| SCHEMBL8375775 | 0.85 | ALOX15 (0.69) | ALOX15ALDH1A1LMNAMAPK1HSD17B10 | |
| SCHEMBL14046581 | 0.85 | ALOX15 (0.66) | ALOX15ALDH1A1LMNAMAPK1HSD17B10 | |
| SCHEMBL19752799 | 0.84 | ALOX15 (0.62) | ALOX15ALDH1A1LMNAMAPK1HSD17B10 | |
| SCHEMBL7668778 | 0.84 | HSD17B10 (0.67) | ALOX15ALDH1A1LMNAMAPK1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260125432-A1 | MALTOSE DEPENDENT DEGRONS, MALTOSE-RESPONSIVE PROMOTERS, STABILIZATION CONSTRUCTS, AND THEIR USE IN PRODUCTION OF NON-CATABOLIC COMPOUNDS | AMYRIS INC (US) | 2026-05-07 | — | — | US | claimed |
| EP-4713469-A1 | METHOD OF REDUCING EMULSION FORMATIONDURING FERMENTATION PROCESS | DSM IP Assets B.V. (NL) | 2026-03-25 | — | — | EP | claimed |
| US-20260071239-A1 | COMPOSITIONS AND METHODS FOR IMPROVED CELL CULTURE EFFICIENCY | AMYRIS INC (US) | 2026-03-12 | — | — | US | claimed |
| EP-4705495-A2 | METHODS FOR IMPROVED CELL CULTURE PERFORMANCE AND PRODUCT RECOVERY | Amyris, Inc. (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4680720-A1 | OPTIMIZED PRODUCTION OF BRANCH POINT COMPOUNDS AND DERIVATIVES USING ALTERNATIVE ISOPENTENYL DIPHOSPHATE-SUPPLYING PATHWAYS | EvodiaBio ApS (DK) | 2026-01-21 | — | — | EP | claimed |
| US-20250283119-A1 | FERMENTATION PROCESSES AND SYSTEMS | MANUS BIO INC (US) | 2025-09-11 | — | — | US | claimed |
| US-12378579-B2 | Method to produce the anti-microbial diterpenoid leubethanol and related serrulatane-type diterpenes | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY (US) | 2025-08-05 | — | — | US | claimed |
| US-12358856-B1 | Compositions and methods for the purification of isoprenoids | Amyris, Inc. (US) | 2025-07-15 | — | — | US | claimed |
| EP-2217711-B2 | PRODUCTION OF ISOPRENOIDS | AMYRIS INC (US) | 2025-04-23 | — | — | EP | claimed |
| EP-4536615-A1 | COMPOSITIONS AND METHODS FOR IMPROVED CELL CULTURE EFFICIENCY | Amyris, Inc. (US) | 2025-04-16 | — | — | EP | claimed |
| US-20230332186-A1 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR RECOVERING WATER-IMMISCIBLE COMPOUNDS FROM MICROBIAL BIOMASS | EUAGORE, LLC | 2023-10-19 | — | — | US | claimed |
| US-11685937-B2 | Recombinant microorganisms for the enhanced production of mevalonate, isoprene, isoprenoid precursors, isoprenoids, and acetyl-CoA-derived products | DANISCO US INC. (US) | 2023-06-27 | — | — | US | claimed |
| US-20230193328-A1 | METHOD TO PRODUCE THE ANTI-MICROBIAL DITERPENOID LEUBETHANOL AND RELATED SERRULATANE-TYPE DITERPENES | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2023-06-22 | — | — | US | claimed |
| EP-3814516-B1 | METHODS FOR RECOVERING WATER-IMMISCIBLE ISOPRENOID COMPOUNDS FROM MICROBIAL BIOMASS | AMYRIS INC (US) | 2023-06-07 | — | — | EP | claimed |
| EP-2024504-B2 | PRODUCTION OF ISOPRENOIDS | AMYRIS INC (US) | 2022-12-14 | — | — | EP | claimed |
| US-11472847-B2 | Genetically encoded system for constructing and detecting biologically active agents | THE REGENTS OF THE UNIVERSITY OF COLORADO (US) | 2022-10-18 | — | — | US | claimed |
| CN-108474009-B | Maltose-dependent degreddeterminants, maltose-responsive promoters, stabilized constructs and their use in the production of non-catabolic compounds | 阿迈瑞斯公司 | 2022-10-04 | — | — | CN | claimed |
| US-20220307059-A1 | METHODS FOR DECOUPLING YIELD AND PRODUCTIVITY OF A NON-CATABOLIC COMPOUND PRODUCED BY A HOST CELL | EUAGORE, LLC | 2022-09-29 | — | — | US | claimed |
| US-11312976-B2 | Methods for recovering water-immiscible isoprenoid compounds from microbial biomass | Amyris, Inc. (US) | 2022-04-26 | — | — | US | claimed |
| EP-3980551-A1 | METHODS FOR DECOUPLING YIELD AND PRODUCTIVITY OF A NON-CATABOLIC COMPOUND PRODUCED BY A HOST CELL | Amyris, Inc. (US) | 2022-04-13 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260125432-A1 | MALTOSE DEPENDENT DEGRONS, MALTOSE-RESPONSIVE PROMOTERS, STABILIZATION CONSTRUCTS, AND THEIR USE IN PRODUCTION OF NON-CATABOLIC COMPOUNDS | MAX, JUND, MYCBP | ALOX15 3772/4885ALDH1A1 4768/4885LMNA 3732/4885 |
| US-12358856-B1 | Compositions and methods for the purification of isoprenoids | GGPS1, HMGCR, DHCR7 | ALOX15 66/4885ALDH1A1 2518/4885LMNA 269/4885 |
| US-20260071239-A1 | COMPOSITIONS AND METHODS FOR IMPROVED CELL CULTURE EFFICIENCY | RHOA, NFATC1, CYP46A1 | ALOX15 22/4885ALDH1A1 2503/4885LMNA 401/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.